Company intelligence / Profile preview

Hydrinity

Nashville, Tennessee, United Stateshydrinity.com ↗

Ownership: Private
Development stage: Commercial

Overview

Hydrinity’s products are clinically tested and have demonstrated rapid results in improving skin hydration and appearance within two weeks. Their proprietary injectable-grade hyaluronic acid formulations are used both in professional practices and for at-home care. The company has achieved significant commercial traction with over 3,000 professional practices using their products across 25 countries as of early 2025.

Therapeutic areas: OtherDermatology
Modalities: Hyaluronic acid-based therapy (Supercharged dual-weight hyaluronic acid)Topical skincare formulations
Industry: Non-Drug Biotech

Drug pipeline

2 assets

Restorative HA Serum

Commercial

Indications: Skin aging, Skin hydration

1 more asset in the full pipeline.

Request access →

Beyond the preview

Go deeper on Hydrinity.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hydrinity.

Explore the full profile